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Abstract. Gastric cancer refers to the development of malign cells that can 
grow in any part of the stomach. With the vast amount of data being collected 
daily in healthcare environments, it is possible to develop new algorithms 
which can support the decision making processes in gastric cancer patients 
treatment. This paper aims to predict, using the CRISP-DM methodology, the 
outcome from the hospitalization of gastric cancer patients who have undergone 
surgery, as well as the occurrence of postoperative complications during sur-
gery. The study showed that, on one hand, the RF and NB algorithms are the 
best in the detection of an outcome of hospitalization, taking into account pa-
tients’ clinical data. On the other hand, the algorithms J48, RF, and NB offer 
better results in predicting postoperative complications. 
Keywords: Data Mining, Clinical Decision Support Systems, CRISP-DM, Gas-
tric Cancer, WEKA. 
1 Introduction 
Gastric cancer (GC) is the development of malign cells that can grow in any part of 
the stomach. It has the potential to invade local and distant organs, the liver, oesopha-
gus, and lungs. There are several histological subtypes of gastric cancer, with adeno-
carcinoma being the most common one – it can be further divided into intestinal and 
diffuse type, according to the Lauren Classification. Other possible and less frequent 
subtypes are squamous, adenosquamous, medullary, and undifferentiated carcinomas. 
Patients are usually asymptomatic, as symptoms often correspond to an advanced 
stage disease [1, 2, 3, 4]. Epidemiologically, GC is the second most frequent cause of 
mortality related to cancer and it is the fourth most common cancer in the world -  it 
has been noticed a decreasing incidence in the past few years [3, 5, 6].The highest 
incidences of this disease are in Eastern Europe, Central and South America, and in 
East Asia. Lower rates occur in North America, Northern Europe, Australia, New 
Zealand, and most parts of Africa. It is more prevalent in males and older people. The 
survival rate within 5 years is below 30%, except in Japan, where 70% of these can-
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cers are diagnosed as stages I and II of the TNM classification. A possible explanation 
for the higher survival rate in Japan is the existence of screening programs, which 
leads to an early diagnosis of this cancer [3, 5, 6].Several risk factors have been iden-
tified, such as tobacco consumption, poor diet and Helicobacter pylori infection. The 
decreasing incidence of gastric cancer can be related to a better control of these infec-
tions – with the improved hygiene conditions and antimicrobial treatment. Neverthe-
less, it has been demonstrated that populations with high predominance of these type 
of infections have low GC rates, which indicates that there are other significant fac-
tors for the development of this disease. Therefore, having a family history of GC, 
low standards of hygiene, being exposed to radiation or even smoking are also factors 
that may increase the risk [3, 4].  
This paper has the main purpose of implementing Data Mining techniques in order 
to develop predictive models that are capable of predicting the outcome of hospitali-
zation of patients with GC who have undergone surgery and the occurrence of post-
operative complications. This article is divided into five sections, which include the 
introduction, proceeded by the state-of-the-art and the methodologies, materials, 
methods, and results. Finally, it is presented the discussion of the results and the con-
clusions and ideas for future work related to this paper. 
2 State-of-the-Art 
2.1 Data Mining 
Nowadays, vast amounts of data are being collected daily in diverse industries and 
healthcare environments are not the exception. In fact, healthcare data has suffered an 
exponential growth throughout the years due to the vast quantity of transactions that 
are performed daily and the digitalization and computerization of healthcare. There-
fore, Data Mining (DM) emerged in response to the overwhelming increase of data in 
medical facilities as a way to transform this data into useful and relevant information 
for healthcare organizations [7]. From a technical point of view, DM can be defined 
as a set of techniques and methods used to analyse and explore large sets of data with 
the intention of discovering previously unknown and meaningful tendencies or pat-
terns. Thus, the goal of DM is to learn from data by extracting new and useful 
knowledge. Subsequently, this information can be used to build predictive models, 
which use past information to determinate what might happen in the future, i.e. to 
give an outcome [8, 9]. Therefore, DM includes descriptive techniques, e.g. clustering 
techniques that are responsible for discovering information hidden in data, and predic-
tive techniques, e.g. classification and regression techniques, that are used to retrieve 
new information from existing data [8, 9, 10]. This paper focuses on predictive tech-
niques, more specifically, on classification techniques. Undeniably, DM has become 
essential in healthcare, namely because of the information acquired by the analysis 
and exploration of medical data, which can help healthcare organizations and their 
caregivers to provide more accurate decisions and, therefore, improve the quality of 
the delivered care [7]. Despite the benefits DM techniques provide to the healthcare 
industry, they have some limitations. In fact, healthcare data has limited accessibility 
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due to its dispersion in different systems whereby medical data must be gathered and 
combined before the DM process. Furthermore, ethical and legal problems may occur 
if the ownership and privacy of healthcare data is not guaranteed. The lack of quality 
of the medical data, which includes missing and inconsistent data, is also another 
limitation since it directly affects DM results [7]. 
2.2 Decision Support Systems and Clinical Decision Support Systems 
Decision Support Systems (DSS) are computer-based systems which are capable of 
supporting problem solving as well as all stages of the decision-making process al-
lowing the decision maker to control the process. However, in order to help the deci-
sion-making process, these systems need knowledge and useful information which 
can be extracted through DM techniques. Thus, as mentioned before, these techniques 
are used to analyse and explore data with the aim of discovering patterns that might 
be helpful for decision-making [11, 12]. In order to health professionals make more 
accurate decisions, DSS are incorporated into healthcare organizations being known 
as Clinical Decision Support Systems (CDSS). These systems were specifically de-
signed to aid caregivers in the clinical decision-making process. For this purpose, 
health providers must enter the data of a specific patient in the system. Once entered, 
the data must be processed and then linked and compared to knowledge present in the 
system so that it can give back useful information and suggestions to the caregivers 
and, therefore, improve the quality of the delivered care [13]. CDSS can perform 
different actions having, nonetheless, the same goal which is to improve the quality 
and efficiency of treatments delivered by healthcare organizations and, therefore, lead 
to higher patient safety and reduce the incidence of adverse events. Firstly, CDSS can 
be used to alert health providers about problems or irregularities that are occurring as 
well as remind them about certain actions that must be performed. Additionally, these 
systems are widely used to give a more accurate diagnosis and to help predicting out-
comes based on patient-specific clinical data provided to the system. Many of these 
systems are also used to assist health professionals, e.g. to calculate the appropriate 
doses of medications, thus reducing the risk of occurring medical errors. Moreover, 
CDSS may also offer suggestions to caregivers giving them guidelines or recommen-
dations in order to perform appropriate care and reduce the likelihood of adverse 
events [13, 14, 15]. 
2.3 Data Mining Techniques 
As mentioned in the previous subsection, the CRISP-DM process was the reference 
model followed in this paper for the development of the DM project. Moreover, Wai-
kato Environment for Knowledge Analysis (WEKA), which is a ML software, was 
used in the Modelling phase to analyse and explore the available data and to create the 
intended models. Thus, a total of five modelling techniques were used with the re-
ferred software in order to induce the DM models: Random Forest (RF), Naïve Bayes 
(NB), Sequential Minimal Optimization (SMO), J48, and JRIP. In a simplified way, 
RF initially selects a bootstrap sample from the training data, which is a random sam-
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ple obtained with replacement, to induce a Decision Tree (DT). Subsequently, this 
step is repeated until an ensemble of DT is created, having each one of them its own 
prediction value. Lastly, the final output, i.e. the prediction, is obtained by combining 
the output from all trees, which corresponds to the most frequent output obtained by 
the ensemble. RF is known as being very efficient as well as one of the most accurate 
classifiers. Moreover, the performance attained by RF is usually improved compara-
tively to single DT [16, 17, 18, 19]. On the other hand, NB is a probabilistic classifier 
that assumes that all variables are equally independent from the value to be predicted 
regardless of the correlations that may exist between them. Thus, this is the reason 
why NB is considered a naïve classifier. This classifier uses the Bayes theorem to 
predict new instances which, given a set of input values, chooses the most probable 
output value as the prediction. NB is known as being one of the most effective algo-
rithms for certain domains, namely to classify text documents. Additionally, NB is 
easily applied and learn fast [19, 20]. SMO corresponds to a new and improved Sup-
port Vector Machine (SVM) algorithm, which has the aim of finding the best function 
that can classify the instances of the training data into the different classes, and 
emerged as a solution for the quadratic programming problem of SVM. Therefore, 
SMO, which is used for training SVM, breaks the referred problem into a set of 
smaller ones that can be resolved analytically, thus being much more simple, faster, 
and easier to use. SVM is commonly used since it is a highly accurate and reliable 
method [21, 22]. The J48 classifier implemented by WEKA corresponds to an en-
hanced implementation of the C4.5 algorithm, which is a DT classifier. In order to 
create the DT for a certain dataset, the referred algorithm recursively divides the data 
generating, in each step, several tests. Subsequently, the test that offers the best in-
formation gain is then chosen. It must be mentioned that J48 is considered one of the 
most powerful and commonly used DT classifier [23, 24, 24]. Lastly, JRIP is a rule 
classifier and corresponds to WEKA’s implementation of the Repeated Incremental 
Pruning to Produce Error Reduction (RIPPER) algorithm. 
2.4 Related Work 
Undeniably, DM techniques are essential tools to aid the decision-making process in 
medical environments and to improve the quality of healthcare facilities as well as the 
care delivered by them. Thus, in the interest of having a better understanding of the 
potential of these tools, some existing works are presented in this subsection. Delen et 
al. (2005) used three DM techniques along with 10-fold cross-validation to develop 
predictive models that could predict breast cancer survivability. More specifically, 
they used two ML algorithms (Artificial Neural Networks (ANN) and DT) as well as 
one statistical method (Logistic Regression (LR)) on a dataset provided by the Sur-
veillance, Epidemiology, and End Results (SEER) program which contained over 
200,000 cases. Additionally, sensitivity analysis was performed on the ANN model 
with the aim of discovering the variables, which influence the prediction of breast 
cancer survivability [26]. The results revealed that the DT model was the best predic-
tor (accuracy of 93.6%), followed by the ANN model (accuracy of 91.2%) and, lastly, 
by the LR model (accuracy of 89.2%), thus proving that DM techniques successfully 
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create predictive models with a high accuracy. Lastly, the sensitivity results showed 
that the grade of the cancer was, without a doubt, the most important variable to pre-
dict breast cancer survivability [27]. Khalilia et al. (2011) resorted to RF, SVM, 
boosting, and bagging on a National Inpatient Sample (NIS) dataset with the intent of 
predicting the risk of not only one but eight chronic diseases. In addition, since the 
dataset was class-imbalanced, these methods were also performed using random sub-
sampling in order to solve this problem. Overall, the RF model gave the best results 
having an average accuracy of 88.79%. Moreover, the results obtained with sub-
sampling were better, thus proving that sub-sampling was able to solve the imbalance 
problem. It must be mentioned that one of the advantages of this study was the fact 
that they successfully predicted the risk of 8 different diseases and not only one [27]. 
3 Methodologies, Material, Methods, and Results 
The dataset that serves as the basis for the study project was provided by a Portuguese 
hospital and is constituted of data from GC patients who have undergone surgical 
procedures. The data contain a set of clinical indicators that are associated to each 
patient. Given that the purpose of this study is to predict two parameters - the result of 
hospitalization and whether the patient will or will not have postoperative complica-
tions, the dataset was divided in two, considering only the attributes that are associat-
ed with each type of goal. The CRISP-DM methodology was implemented in this 
work in the way described in the following points, where each of them corresponds to 
a phase. 
3.1 Business Understanding 
Among the different surgeries related to GC, many of them originate postoperative 
complications and have very low success rates. Understanding anticipated results of a 
surgery could assist doctors in the decision of choose the best option for each patient. 
Thus, this work intends to evaluate different DM techniques in order to determine the 
ones that provide the best results at the predictive capacity level. 
3.2 Data Understanding 
At this stage, it was necessary to extract and analyze the dataset provided by the hos-
pital. It were identified 65 attributes and 154 instances. The number of existing attrib-
utes is adequate for what is intended, but the number of instances is low, taking into 
account the characteristics of the DM. The individual meanings of each attribute were 
verified to understand what kind of influence they might have in the analysis. The 
existing data are in the nominal type and, for each of them, the frequency of each 
label was characterized. Some attributes have conditions of compatibility between 
them such as, for example, the number of invaded glands must be always lower than 
the number of resected glands, and there is only lymphatic resection if exists resected 
glands. At first sight, one of the attributes in the dataset that appears to have influence 
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in the results is the cancer stage, which indicates the severity of the disease. This 
phase of Data Understanding aims to detect the inconsistencies and verify the dupli-
cated data. Furthermore, it is also important to find the redundant data, observe if the 
data are in agreement with each other, and check the missing values. 
3.3 Data Preparation 
In this step, the data are prepared in order to: - Eliminate those that are repeated 
and those that have relations of dependence; - Eliminate those that have many attrib-
utes without filling; - Remove inconsistencies; - Create groups such as age groups; -
Add new necessary attributes. It should be noted that the data are treated in two dis-
tinct datasets, one for each of the two analyses considered. For the dataset that is re-
lated to the complications, a new column had to be created to predict this result. In 
each dataset, the instances that were removed were those in which there were at least 
four null values, in which the attribute "Surgery Performed" was null, and still those 
that presented null values in the columns that were intended to predict the columns of 
the result of the hospitalization and the occurrence of postoperative complications. At 
this stage, it was still necessary to correct some errors and make some changes to the 
dataset. As an example, since the label “99” of the variable “Degree Differentiation” 
was wrong, it was replaced by a null value, as happened with the label “3” in the vari-
able “Reconstruction”. It was also necessary to create a new label in the column of 
attribute “Lymphatic Resection” for cases in which no glands have been resected. 
3.4 Modeling 
In this phase, the Data Mining Model (DMM) is constructed according to a target 
variable (T), the choices regarding the scenarios considered (S), the DM techniques 
chosen (DMT), the approaches followed (DA), and the sampling methods used (SM): 
 T = {Hospitalisation Result, Surgery Complications} 
 S = {S1, S2, S3, S4, S5} 
 DMT = {JRIP, J48, RandomForest, SMO, NaiveBayes} 
 DA = {With Oversampling, Without Oversampling} 
 SM = {Cross-validation 10 Folds, Percentage Split 66%} 
Where for DM Hospitalisations Result (DM1): 
 S1 = {all attributes} 
 S2 = {Resected Glands, Cancer Stage, Surgery Performed, Lymphatic Re-
section, Performed Surgery Aim, Num Surgery Complications, ASA, Hospi-
talisation Result} 
 S3 = {Sex, Provenance, Motive, Age Group, Hospitalisation Result} 
 S4 = {HPreOp, HPosOp, Resected Glands, Degree Differentiation, Invaded 
Glands, Lymphatic Resection, Hospitalisation Result} 
 S5 = {Local P T, Surgery Performed, Reconstruction, Operating Room Dis-
charge, Performed Surgery Aim, Num Surgery Complications, Access Sur-
gery, ASA, Hospitalisation Result} 
And for DM Surgery Complications (DM2): 
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• S1 = {all attributes} 
• S2 = {Sex, Surgery Complications} 
• S3 = {Sex, Provenance, Motive, Age Group, Surgery Complications} 
 S4 = {HPreOp, Resected Glands, Degree Differentiation, Invaded Glands, T, 
Cancer Stage, Surgery Complications} 
• S5 = {Local P T, Surgery Performed, Reconstruction, Performed Surgery 
Aim, Access Surgery, ASA, Surgery Complications}. 
The choice of the various samples was based on sample S1. To obtain the sample 
S2, it had been applied the filter “AttributeSelection” in WEKA. This filter considers 
only the most relevant attributes, reducing significantly the number of attributes ana-
lysed. Scenarios S3, S4, and S5 contain the attributes that were chosen by group ele-
ments, taking into account the patient’s own data and the surgery and tumour data. 
This methodology was used in both cases, for DM1 and DM2. In the case of the 
DM1, there were only six patients who died after the hospitalization and two who 
maintained their own state. Thus, as these data were insufficient, it was necessary to 
do oversampling in these instances, in order to increase the number of data of “died” 
and “same state”. Oversampling is a technique of duplication of data that should be 
used when there are few instances for analysis. On the other hand, in the case of 
DM2, there was no oversampling done because the result presents 23 patients who 
had surgical complications and 63 who did not, which corresponds to a sufficient 
number of data for analysis. Thus, the DMM that is given by DMM = {T, S, DMT, 
DA, SM} represents 2 x 5 x 5 x 1 x 2 = 100 simulations (two targets, five scenarios, 
five DM techniques, one approach by target, and two sampling methods). 
3.5 Evaluation 
After the construction of the models, they are analyzed and evaluated to see if they 
adequately fulfil the intended objectives. The verification of the models is carried out 
with the results of the simulations, considering the accuracy, sensitivity, specificity, 
and execution time of the technique as important parameters of the analysis. Tables 1 
and 2 show the best values obtained for accuracy, sensitivity, and specificity accord-
ing to each of the techniques used. For each value found, the execution time of the 
respective DM technique is associated. 
Table 1. DM1 – Hospitalization Result. 
DM Technique Scenario Sampling Method Accuracy Time Sensitivity Time Specificity Time 
JRIP S5 Cross-validation 91.4 0.00 91.1 0.00 78.9 0.00 
J48 
S2 Cross-validation 89.2 0.06 89.3 0.06   
S5 Percentage Split     88.6 0.00 
RandomForest S1 Cross-validation 97.8 0.49 98.1 0.49 99.8 0.49 
SMO 
S1 Cross-validation 91.4 0.2 90.6 0.20   
S1 Percentage Split     71.3 0.16 
NaiveBayes S1 Cross-validation 95.7 0.02 95.7 0.02 89.3 0.02 
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Table 2. DM2 – Surgery Complications. 
DM Technique Scenario Sampling Method Accuracy Time Sensitivity Time Specificity Time 
JRIP 
S5 Cross-validation 72.6 0.00     
S2, S5 Percentage Split   83.3 0.00   
S2, S4 Cross-validation     26.7 0.00 
J48 
S5 Percentage Split 83.2 0.00   64.0 0.00 
S2, S4 Percentage Split   83.3 0.01   
RandomForest S5 Percentage Split 82.1 0.01 83.3 0.01 48.7 0.01 
SMO 
S1 Percentage Split 69.0 0.00     
S2, S3, S4, 
S5 
Percentage Split 
  83.3 0.01 
 
 
S1 Cross-validation     35.9 0.00 
NaiveBayes 
S1 Percentage Split 82.1 0.00     
S2, S3, S4, 
S5 
Percentage Split 
  83.3 0.00 
 
 
S1 Percentage Split     48.7 0.00 
 
As seen from the tables above, there are methods that provide high accuracy results 
that can be used for future work. In general, it is observed that the execution times of 
the algorithms are low, and the values of accuracy are high. 
4 Discussion 
From the analysis of tables 4 and 5, it is observed that the results of DM1 present 
values of accuracy, sensitivity, and specificity higher than those of DM2. This worse 
result is possible associated with the considered attributes that may not have a great 
influence on the postoperative complications. Another of the differences between 
DM1 and DM2 is related to the method that presents better results in the classifica-
tion. In DM1, cross-validation yields better results whereas in DM2 it is the percent-
age split that has the best results. Regarding the selected scenarios, S1 and S5 have a 
high predictive character in DM1 and scenarios S2, S4, and S5 are practically equiva-
lent and yield better results in DM2. It should be noted that in DM2, with scenario S2, 
that only has the attribute “sex” and the classification attribute, it is possible to obtain 
good values of predictive capacity. However, using, for example, JRIP, the returned 
rule is simply "no complications", without being associated with the sex attribute. 
This result indicates that this scenario is not suitable for the intended objectives. The 
RF and NB techniques present values above 95% in accuracy and sensitivity when 
used with sample S1, through the cross-validation method for DM1 analysis. Thus, 
these techniques are the most suitable to be used for DM because they present the best 
values. Between RF and NB techniques, there is one fundamental difference: RF is 
much slower in its execution, which can have considerable effects on processing da-
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tasets with thousands of instances. It can still be observed that the values of specificity 
are low in DM2, which removes credibility to these results. Despite this, DM2 pre-
sents good values for accuracy and sensitivity, especially when using the sample S5 
and the J48, RF or NB techniques. 
5 Conclusions and Future Work 
In conclusion, it was verified that the dataset of DM1 produced good results for the 
construction of predictive models, at the level of gastric cancer surgeries. In this case, 
the RF technique and the cross-validation method should be used. On the other hand, 
it was also found that not all data allow to obtain good results and that, therefore, they 
should be reanalysed, such as the DM2 data. Thus, it can be concluded that the RF 
and NB algorithms are good options in the detection of the result of hospitalization 
from the clinical data of the patient and that the algorithms J48, RF, and NB offer 
good predictions for the existence of postoperative complications. To complement the 
developed work, a new study could be done, with a larger dataset and a bigger num-
ber of instances, in order to determine if the results would be maintained for the RF 
and NB techniques and if the execution time associated with these algorithms would 
be acceptable. 
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